Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Sarcoma, Myeloid 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 29fludarabine phosphate 19Filgrastim 18Whole-Body Irradiation 15Mycophenolic Acid 15Methotrexate 15Peripheral Blood Stem Cell Transplantation 14Cytarabine 14Cyclosporine 13Busulfan 12Methylprednisolone 10Thiotepa 9Antilymphocyte Serum 9Tacrolimus 8Granulocyte Colony-Stimulating Factor 8Clofarabine 8Vincristine 7Radiotherapy 7Melphalan 7Cord Blood Stem Cell Transplantation 7fludarabine 6Leucovorin 6Dexamethasone 6merphos 5Mercaptopurine 5Etoposide 5Daunorubicin 5Cladribine 5Therapeutics 4Prednisone 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Biphenotypic, Acute × Leyk × Clear all
NCT00557193 2024-07-15

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
218 enrolled 21 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡